Evidence map›Paper›PMID 42196220›Full record

ArticleInternational journal of molecular sciences2026

MOTCS: A Cancer Subtype Classification and Key Biomarker Recognition Model Based on Multi-Omics Data Integration of Transformer.

Ping Meng, Guohua Wang, Tianjiao Zhang

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ping MengFaculty of Computing, Harbin Institute of Technology, Harbin 150001, China.ORCID 0009-0002-2547-3974
Guohua WangFaculty of Computing, Harbin Institute of Technology, Harbin 150001, China.
Tianjiao ZhangSchool of Computer Science and Artificial Intelligence, Northeast Forestry University, Harbin 150040, China.ORCID 0000-0001-9807-8620

Funding

Fundamental Research Funds for the Central Universities 2572025JT05-02Key Program of the National Natural Science Foundation of China 62531007National Natural Science Foundation of China 62473094Natural Science Foundation of Heilongjiang Province LH2024F003
6 · The paper itself

Abstract

Cancer, as a complex disease with high heterogeneity, is gradually shifting from standardization to individualization. Current research indicates that integrating multi-omics data, including genome, transcriptome, and epigenome, can more comprehensively reveal the molecular features of tumors, thereby providing a more reliable basis for subtype classification. It is worth noting that driver genes, as key factors directly involved in tumorigenesis and development, when combined with multi-omics data, improve model interpretability. We proposed a cancer subtype classification model named MOTCS, which consists of four key steps: (1) The extraction of driver gene features from existing databases and the execution of preliminary feature selection for non-driver genes in different omics data; (2) the use of the transformer encoder to conduct feature representation learning for non-driver gene features and driver gene features, respectively; (3) the non-driver gene feature embeddings and driver gene feature embeddings of each omics learned are concatenated and input into the MLP classifier to obtain the classification probabilities of each subtype. (4) By integrating the above features through view association discovery networks, cross-omics feature representations are learned so as to achieve effective classification. The results show that MOTCS outperformed existing methods across all four datasets and that the introduction of driver genes will enhance the classification performance of MOTCS. MOTCS achieved precise classification of cancer subtypes by mining the feature embeddings of driver genes and non-driver gene features.

Indexed as

Biomarkers, TumorComputational BiologyNeoplasmsClassification AlgorithmsGenomicsHumansMultiomicsBiomarkers, Tumorcancer subtypedriver genemulti-omicstransformer

Identifiers

PMID42196220
PMCPMC13207841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.